GlobeNewswire Inc | Oct 8, 2021 08:00AM EDT

October 08, 2021

TAMPA, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that it will host an Investor Day on Friday, October 15, 2021, from 8:00 AM to approximately 12:00 PM ET. Key Opinion Leaders and members of the Pacira executive team will provide updates on the Companys commercial products and pipeline opportunities. The event is taking place at ThePaciraInnovation and Training Center at Tampa (the PITT). In-person attendance requires advance registration and is subject to space limitations.

An agenda as well as a live webcast of the event will be accessible through PaciraInvestorDay.com. An archived replay of the webcast will also become available through the same link following the conclusion of the event.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients journeys along the neural pain pathway. The companys long-acting local analgesic, EXPAREL (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure and releases them over a desired period of time. In April 2019, Pacira acquired the iovera system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Company Contact:Pacira BioSciences, Inc.Christian Pedetti(973) 254-4387Christian.Pedetti@pacira.com